Phico Therapeutics secures £550,000 for Anti-Bacterial to target MRSASeptember 05, 2004Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network (OION), Europe's leading technology business angel network. Phico's anti-bacterial technology, known as SASPject, is effective against all bacteria but can uniquely be targeted to destroy only harmful bacteria while leaving "good" skin and gut bacteria intact. The funding will enable Phico to take SASPject through to clinical trials. Dr Heather Fairhead, Chief Executive Officer of Phico Therapeutics, said: "Phico's anti-bacterial SASPject technology is effectively a lethal injection for bacteria. Uniquely, SASPject combines an anti-bacterial protein (SASP) with a delivery vector programmed to inject the SASP protein directly into selected bacteria, so it wipes out only harmful bacteria. It is expected to have far fewer side effects than conventional antibiotics. SASPject can de-activate or 'turn off' bacterial DNA, putting bacteria into a state of suspended animation and halting the spread of infection, giving the immune system time to eliminate the bacteria. It is extremely effective against antibiotic resistant bacteria, such as the MRSA superbug, with SASPject turning off the genes that cause resistance to antibiotics. Conventional antibiotics cannot do this." Dr Fairhead commented on how the investment will help Phico: "Phico has already demonstrated that SASPject works in the laboratory, and the funding raised through Oxfordshire Investment Opportunity Network will help to take us through to the start of human clinical trials in 2005, as the next step in the process of bringing our products to market. For this funding round, we used a number of investment networks around the country and found OION to be one of the most effective. The presentation was well-organised and OION's manager was very proactive, attracting investment from investors in Portsmouth as well as Oxford." Jon Cox, Manager of Oxfordshire Investment Opportunity Network, said: "Phico offered the OION investors a unique and very relevant technology that has already demonstrated results, backed by a knowledgeable and experienced management team. On this occasion, members from our sister network, Solent Investment Opportunity Network (SION), invested alongside the OION investors enabling Phico to secure the funds needed to commercialise their technology." Oxford Innovation |
|||||||||||||||||||||
| Related Bacteria Current Events and Bacteria News Articles Plasma produces KO cocktail for MRSA MRSA (methicillin-resistant Staphylococcus Aureus) and other drug-resistant bacteria could face annihilation as low-temperature plasma prototype devices have been developed to offer safe, quick, easy and unfailing bactericidal cocktails. Knockouts in human cells point to pathogenic targets Whitehead researchers have developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens, according to their paper in Science. First-ever blueprint of a minimal cell is more complex than expected What are the bare essentials of life, the indispensable ingredients required to produce a cell that can survive on its own? Factors from common human bacteria may trigger multiple sclerosis Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. New study finds MRSA on the rise in hospital outpatients The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases. Researchers establish common seasonal pattern among bacterial communities in Arctic rivers New research on bacterial communities throughout six large Arctic river ecosystems reveals predictable temporal patterns, suggesting that scientists could use these communities as markers for monitoring climate change in the polar regions. Biologists discover bacterial defense mechanism against aggressive oxygen Bacteria possess an ingenious mechanism for preventing oxygen from harming the building blocks of the cell. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss Census of Marine Life scientists have inventoried an astonishing abundance, diversity and distribution of deep sea species that have never known sunlight - creatures that somehow manage a living in a frigid black world down to 5,000 meters (~3 miles) below the ocean waves. More Bacteria Current Events and Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||